Dosing Cefepime for Renal Function Does Not Completely Prevent Neurotoxicity in a Patient with Kidney Transplant

Percy Guanzon Balderia, Aditya Chandorkar, Yongwoo Kim, Soumya Patnaik, Joshua Sloan, George Charles Newman

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Dosing cefepime for renal function does not completely prevent neurotoxicity in a kidney transplant patient. Cefepime neurotoxicity has been reported primarily among patients with renal insufficiency who received standard doses of the antibiotic. We report a case of nonconvulsive status epilepticus from dose-adjusted cefepime in a kidney transplant patient. The timing of symptoms along with clinical and electroencephalographic improvement after discontinuation of cefepime was critical to the diagnosis. Whether we should adjust the dose of cefepime differently in a patient with transplanted kidney to prevent neurotoxicity is unknown.

Original languageEnglish (US)
Pages (from-to)e33-e34
JournalJournal of Patient Safety
Volume14
Issue number2
DOIs
StatePublished - Jun 1 2018
Externally publishedYes

Keywords

  • cefepime
  • encephalopathy
  • seizures
  • transplants

Fingerprint Dive into the research topics of 'Dosing Cefepime for Renal Function Does Not Completely Prevent Neurotoxicity in a Patient with Kidney Transplant'. Together they form a unique fingerprint.

Cite this